FDAClass IIRecall started May 10, 2024

Duloxetine Delayed-Release Cap USP 30 mg Recall: Impurity Out of Spec

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

What is the FDA recall status?

The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.

How FDA enforcement data reports status

Why was Duloxetine Delayed-Release Cap USP 30 mg recalled?

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

What should I do if I have this product?

Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.

Full product description

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

Which lot codes, UPCs or models are affected?

Lot #: J2022G, Exp: 01/01/2025

Agency record number
D-0505-2024
Product
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Recalling firm
Preferred Pharmaceuticals, Inc.
Quantity
66 bottles of 30 tablets
Distribution
Product distributed to CA, FL, OK, KS and CT
Recall started
May 10, 2024
Report date
May 29, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls